Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. RKLB
2. SION
3. SPY
4. NVDA
5. CSQR
6. B
7. MNDY
8. ACH
9. RHP
10. SLN

Go back to Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
(NASDAQ: VTRS) Delayed: 16.28 -0.15 (0.91%)
Previous Close $16.43    52 Week High $ 
Open $16.30    52 Week Low $ 
Day High $16.71    P/E N/A 
Day Low $16.13    EPS $ 
Volume 13,225,997